Monaco Asset Management’s Maravai LifeSciences MRVI Stock Holding History

Monaco Asset Management’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$4.96M	Sell	647,000 -1,584,026	-71%	-$11M	0.61%	25
2026 Q2	$13.9M	Sell	2,231,026 -1,189,994	-35%	-$5.14M	1.11%	17
2026 Q1	$9.7M	Sell	3,421,020 -39,170	-1%	-$133K	1.79%	18
2025 Q4	$11.2M	Sell	3,460,190 -196,147	-5%	-$660K	1.95%	14
2025 Q3	$10.5M	Buy	3,656,337 +2,775,372	+315%	+$7.09M	0.64%	16
2025 Q2	$2.12M	Buy	880,965 +45,100	+5%	+$94.8K	0.37%	44
2025 Q1	$1.85M	Buy	835,865 +544,501	+187%	+$2.15M	0.38%	35
2024 Q4	$1.59M	Buy	291,364 +216,364	+288%	+$1.39M	0.23%	48
2024 Q3	$623K	Sell	75,000 -125,000	-63%	-$1.08M	0.09%	62
2024 Q2	$1.43M	Buy	200,000 +41,849	+26%	+$361K	0.23%	38
2024 Q1	$1.37M	Sell	158,151 -153,059	-49%	-$1.04M	0.41%	38
2023 Q4	$2.04M	Buy	+311,210	New	+$2.01M	0.6%	41

Other funds holding MRVI

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

First Eagle Investment Management New York $63.7B AUM 20.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

General American Investors New York $1.71B AUM 30.1% 1-Year Est. Return

Royce & Associates New York $11B AUM 39.4% 1-Year Est. Return

Hillsdale Investment Management Toronto, Ontario, Canada $4.42B AUM 54.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $294B AUM 47.59% 1-Year Est. Return

Monaco Asset Management's MRVI Position: Q3 2026 in Review

Monaco Asset Management reduced its Maravai LifeSciences (MRVI) stake by 71% in Q3 2026, selling an estimated $11M and leaving 647,000 shares worth $4.96M. The position accounts for 0.61% of the portfolio, ranked #25.

Monaco Asset Management first reported a position in MRVI in Q4 2023 and has held it in 12 quarters since. The position peaked at $13.9M in Q2 2026. 108 funds tracked by Wall St. Rank hold MRVI as of Q3 2026.

Monaco Asset Management held 647,000 shares of Maravai LifeSciences worth $4.96M as of Q3 2026.
Monaco Asset Management sold 1,584,026 Maravai LifeSciences shares in Q3 2026, an estimated $11M.
Maravai LifeSciences made up 0.61% of Monaco Asset Management's portfolio in Q3 2026, its #25 holding.
Monaco Asset Management first reported a position in Maravai LifeSciences in Q4 2023 and has held it in 12 quarters since.
Monaco Asset Management's Maravai LifeSciences position peaked at $13.9M in Q2 2026.
108 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q3 2026.

Based on Monaco Asset Management's 13F filing for Q3 2026, filed 9 Nov 2026.